Issued Patents All Time
Showing 26–47 of 47 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11180757 | 17β-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and methods of use thereof | Gregory Hinkle, Frederic Tremblay, Noura S. Abul-Husn, Omri GOTTESMAN, Alexander Li +6 more | 2021-11-23 |
| 11045522 | Glucagon-like peptide 1 receptor agonists and uses thereof | Yang Wei, Haruka Okamoto, Samuel Davis, Andrew J. Murphy | 2021-06-29 |
| 10995146 | Methods of treating severe insulin resistance by interfering with glucagon receptor signaling | Haruka Okamoto, Stephen R. Jaspers, Joyce Harp | 2021-05-04 |
| 10961583 | Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the PNPLA3 I148M variation | Yurong Xin, Xiping Cheng, Frederick Dewey, Tanya Teslovich Dostal, Claudia Schurmann +2 more | 2021-03-30 |
| 10947310 | Fusion protein comprising apelin and an anti-APLNR antibody | Panayiotis Stevis, Andrew J. Murphy, Yonaton Ray, Jee H. Kim, Ivan B. Lobov | 2021-03-16 |
| 10787647 | HSD17B13 variants and uses thereof | Noura S. Abul-Husn, Omri GOTTESMAN, Alexander Li, Xiping Cheng, Yurong Xin +5 more | 2020-09-29 |
| 10626173 | Method for treating pathological angiogenesis by administering an antibody that inhibits APLNR | Panayiotis Stevis, Andrew J. Murphy, Yonaton Ray, Jee H. Kim, Ivan B. Lobov | 2020-04-21 |
| 10618968 | Antigen-binding proteins that activate the leptin receptor | Panayiotis Stevis, Judith Altarejos | 2020-04-14 |
| 10582702 | Non-human animals having an engineered ANGPTL8 gene | Viktoria Gusarova, Andrew J. Murphy, Dayong Guo | 2020-03-10 |
| 10550192 | Antigen-binding proteins that antagonize leptin receptor | Panayiotis Stevis, Judith Altarejos | 2020-02-04 |
| 10548302 | Fibrillin-1 mutations for modeling neonatal progeroid syndrome with congenital lipodystrophy | Charleen Hunt, Jason Mastaitis, Guochun Gong, Ka-Man Venus Lai, Aris N. Economides | 2020-02-04 |
| 10526403 | Anti-activin A antibodies and uses thereof | Esther Latres, Andrew J. Murphy, George D. Yancopoulos, Lori C. Morton | 2020-01-07 |
| 10519240 | Anti-FGFR1c antibody-FGF21 fusion proteins | George D. Yancopoulos, Andrew J. Murphy, David Buckler, Kihwa Kang | 2019-12-31 |
| 10442856 | Methods of treating obesity with anti-ANGPTL8 antibodies | Viktoria Gusarova, Andrew J. Murphy | 2019-10-15 |
| 10259870 | Anti-ANGPTL8 antibodies and uses thereof | Viktoria Gusarova, Andrew J. Murphy, David Buckler | 2019-04-16 |
| 10253102 | Antigen-binding proteins that activate the leptin receptor | Panayiotis Stevis, Judith Altarejos | 2019-04-09 |
| 10189901 | Methods for improving cardiac function by administering an antibody that activates APLNR | Panayiotis Stevis, Andrew J. Murphy, Yonaton Ray, Jee H. Kim, Ivan B. Lobov | 2019-01-29 |
| 10155811 | APLNR modulators and uses thereof | Panayiotis Stevis, Andrew J. Murphy, Yonaton Ray, Jee H. Kim, Ivan B. Lobov | 2018-12-18 |
| 10023644 | Antigen-binding proteins that activate the leptin receptor | Panayiotis Stevis, Judith Altarejos | 2018-07-17 |
| 9718881 | Anti-Activin A antibodies and uses thereof | Esther Latres, Andrew J. Murphy, George D. Yancopoulos, Lori C. Morton | 2017-08-01 |
| 9657099 | Anti-glucagon antibodies | Haruka Okamoto | 2017-05-23 |
| 9644018 | Antibody modulators of APLNR | Panayiotis Stevis, Andrew J. Murphy, Yonaton Ray, Jee H. Kim, Ivan B. Lobov | 2017-05-09 |